Castle Biosciences
CSTL • NASDAQ • Stock Fundamentals
Castle Biosciences is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Derek J. Maetzold, with a market cap of $637.2M.
Market Cap$637.2M
Employees638.0
CEODerek J. Maetzold
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 3, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Castle Biosciences FAQ
Common questions about Castle Biosciences
Castle Biosciences (CSTL) has a market capitalization of $637.2M and trades on NASDAQ.
Castle Biosciences has approximately 638 employees.